Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
3(17%)
Results Posted
30%(3 trials)

Phase Distribution

Ph not_applicable
9
50%
Ph phase_1
4
22%
Ph phase_2
5
28%

Phase Distribution

4

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
4(22.2%)
Phase 2Efficacy & side effects
5(27.8%)
N/ANon-phased studies
9(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

18

all time

Status Distribution
Active(5)
Completed(10)
Other(3)

Detailed Status

Completed10
Recruiting3
Not yet recruiting2
unknown2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (22.2%)
Phase 25 (27.8%)
N/A9 (50.0%)

Trials by Status

not_yet_recruiting211%
recruiting317%
completed1056%
suspended16%
unknown211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07832435Phase 2

A Phase 2, Placebo-Controlled Study of Oral RXC008 for Crohn's Strictures

Not Yet Recruiting
NCT07724106Phase 1

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

Recruiting
NCT05235360Not Applicable

Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention

Completed
NCT07668466Phase 1

Intradiscal rhGDF-6 for the Treatment of Lumbar Disc Degeneration

Not Yet Recruiting
NCT07035054Phase 2

Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Completed
NCT04074616Not Applicable

Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation

Completed
NCT06214338Not Applicable

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

Completed
NCT05158413Not Applicable

High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety

Recruiting
NCT06264622Not Applicable

ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension

Recruiting
NCT05178667Not Applicable

Food Supplement Effect on Overweight or Moderate Obesity

Completed
NCT05485818Phase 2

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Completed
NCT02493712Phase 2

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Completed
NCT04439695Phase 1

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Completed
NCT01601093Phase 2

Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

Suspended
NCT01056653Not Applicable

Fathers and Late Preterm Babies Study

Completed
NCT00549523Phase 1

A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults

Completed
NCT02114619Not Applicable

Comparative Study of Different I-131 Doses in Graves' Disease

Unknown
NCT01555424Not Applicable

Vitamin D Fortified Cheese and Well-being in the Institutionalized Elderly

Unknown

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18